Patents by Inventor Matthew Fyfe

Matthew Fyfe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090281060
    Abstract: Compounds of Formula (I), R1-A-V—B—R2; or pharmaceutically acceptable salts thereof, are agonists of GPR116 and are useful as regulators of satiety, e.g. for the treatment of obesity, and for the treatment of diabetes.
    Type: Application
    Filed: December 23, 2004
    Publication date: November 12, 2009
    Applicant: PROSIDION LIMITED
    Inventors: Matthew Fyfe, John King-Underwood, Lisa Sarah Bertram (Gardner), Gerard Hugh Thomas, Martin Procter, Chrystelle Rasamison, Karen Schofield
  • Publication number: 20080242869
    Abstract: Compounds of Formula (I) or pharmaceutically acceptable salts thereof, are useful in the prophylactic and therapeutic treatment of hyperglycemia and diabetes.
    Type: Application
    Filed: April 19, 2005
    Publication date: October 2, 2008
    Inventor: Matthew Fyfe
  • Publication number: 20080015358
    Abstract: A process for the production of fluorinated compound formula (I) comprising fluorination of a protected aminothiazole. Compounds formula (I) are useful in the preparation of activators of glucokinase.
    Type: Application
    Filed: August 12, 2005
    Publication date: January 17, 2008
    Inventors: Matthew Fyfe, Frederic Naud
  • Publication number: 20070281946
    Abstract: Compounds of Formula (I): or pharmaceutically acceptable salts thereof, are useful in the prophylactic and therapeutic treatment of hyperglycemia and diabetes.
    Type: Application
    Filed: April 16, 2007
    Publication date: December 6, 2007
    Inventors: Matthew Fyfe, Lisa Gardner, Maseo Nawano, Martin Procter, Chrystelle Rasamison, Karen Schofield, Vilasben Shah, Kosuke Yasuda
  • Publication number: 20070122367
    Abstract: The present invention relates to certain resorcinol derivatives and their use as skin lightening agents.
    Type: Application
    Filed: November 21, 2006
    Publication date: May 31, 2007
    Applicants: PFIZER INC., PFIZER PRODUCTS INC.
    Inventors: Stuart Bradley, Eric Collington, Matthew Fyfe, Martin Procter, Colin Sambrook Smith
  • Publication number: 20050282899
    Abstract: The present invention relates to certain resorcinol derivatives and their use as skin lightening agents.
    Type: Application
    Filed: December 2, 2004
    Publication date: December 22, 2005
    Inventors: Stuart Bradley, Eric Collington, Matthew Fyfe, Martin Procter, Colin Sambrook Smith
  • Publication number: 20050107427
    Abstract: The present invention is directed to a new class of 6-benzyl urea/thiourea-quinolin-2-one derivatives and 2-oxo-6-benzylurea/thiourea-chromene derivatives. These compound are androgen antagonists and are useful in the treatment of alopecia, acne and other conditions associated with inappropriate activation of the androgen receptor.
    Type: Application
    Filed: February 10, 2004
    Publication date: May 19, 2005
    Inventors: Daniel Du, Martin Procter, Matthew Fyfe, Vilasben Shah, Geoffrey Williams, Karen Schofield
  • Publication number: 20050085466
    Abstract: The present invention is directed to a new class of 6-sulfonamido-quinolin-2-one and 6-sulfonamido-2-oxo-chromene derivatives to their use as androgen antagonists, and to relieve conditions associated with inappropriate activation of the androgen receptor.
    Type: Application
    Filed: January 15, 2004
    Publication date: April 21, 2005
    Inventors: Daniel Du, Matthew Fyfe, Martin Procter, Karen Schofield, Vilasben Shah, Geoffrey Williams
  • Publication number: 20050004367
    Abstract: The present invention is directed to a new class of 6-sulfonamide quinoline and chromene derivative and to their use as androgen antagonists.
    Type: Application
    Filed: March 16, 2004
    Publication date: January 6, 2005
    Inventors: Daniel Du, Matthew Fyfe, Martin Procter, Karen Schofield, Vilasben Shah, Geoffrey Williams
  • Patent number: D1026210
    Type: Grant
    Filed: March 4, 2022
    Date of Patent: May 7, 2024
    Assignee: Fisher & Paykel Healthcare Limited
    Inventors: Sascha Kristopher Zoellner, Katie Fyfe, Kevin Blake Powell, James Alexander Gordon, Carsten Ma On Wong Corazza, Graeme Lachlan Vincent, Matthew Joseph Lucas, Neil Gray Duthie, Jojo Santos Badenas, Sean Alexander Craig, Andrew Derek Clark